These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 32131709)
1. Structural Doubling Time Predicts Overall Survival in Patients with Medullary Thyroid Cancer in Patients with Rapidly Progressive Metastatic Medullary Thyroid Cancer Treated with Molecular Targeted Therapies. Yeh T; Yeung M; Sherman EJ; Tuttle RM; Sabra MM Thyroid; 2020 Aug; 30(8):1112-1119. PubMed ID: 32131709 [No Abstract] [Full Text] [Related]
2. Prolongation of tumour volume doubling time (midDT) is associated with improvement in disease-specific survival in patients with rapidly progressive radioactive iodine refractory differentiated thyroid cancer selected for molecular targeted therapy. Sabra MM; Sherman E; Tuttle RM Clin Endocrinol (Oxf); 2019 Apr; 90(4):617-622. PubMed ID: 30706513 [TBL] [Abstract][Full Text] [Related]
3. Tumor volume doubling time of pulmonary metastases predicts overall survival and can guide the initiation of multikinase inhibitor therapy in patients with metastatic, follicular cell-derived thyroid carcinoma. Sabra MM; Sherman EJ; Tuttle RM Cancer; 2017 Aug; 123(15):2955-2964. PubMed ID: 28369717 [TBL] [Abstract][Full Text] [Related]
4. [Progression of diagnosis and treatment of medullary thyroid carcinoma]. Wang X; Li C; Huang L; Shui CY; Liu W; Cai YC; Sun RH; Zhou YQ; Jiang J; Wang W; Zeng DF Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Apr; 54(4):306-310. PubMed ID: 30991785 [No Abstract] [Full Text] [Related]
5. Survival in medullary thyroid carcinoma patients who fail to achieve a biochemical cure: implications of postoperative 1-month calcitonin levels and targeted therapy. Song Y; He Y; Kong Z; Peng B; Li H; Ning Y; Song N; Liu S World J Surg Oncol; 2024 Sep; 22(1):249. PubMed ID: 39267073 [TBL] [Abstract][Full Text] [Related]
6. Tumor Grade Predicts for Calcitonin Doubling Times and Disease-Specific Outcomes After Resection of Medullary Thyroid Carcinoma. Nigam A; Xu B; Spanheimer PM; Ganly I; Tuttle RM; Wong RJ; Shaha AR; Ghossein RA; Untch BR Thyroid; 2022 Oct; 32(10):1193-1200. PubMed ID: 35950622 [No Abstract] [Full Text] [Related]
7. Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma. Grubbs EG; Williams MD; Scheet P; Vattathil S; Perrier ND; Lee JE; Gagel RF; Hai T; Feng L; Cabanillas ME; Cote GJ Thyroid; 2016 Nov; 26(11):1553-1562. PubMed ID: 27610696 [TBL] [Abstract][Full Text] [Related]
8. F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients. Terroir M; Caramella C; Borget I; Bidault S; Dromain C; El Farsaoui K; Deandreis D; Grimaldi S; Lumbroso J; Berdelou A; Hadoux J; Hescot S; Hartl D; Baudin E; Schlumberger M; Leboulleux S Thyroid; 2019 Oct; 29(10):1457-1464. PubMed ID: 31530235 [No Abstract] [Full Text] [Related]
9. Medullary Thyroid Carcinoma: Prognostic Variables And Tumour Markers Affecting Survival. Hassan A; Siddique M; Riaz S; Khan AI; Nawaz MK; Bashir H J Ayub Med Coll Abbottabad; 2018; 30(Suppl 1)(4):S627-S632. PubMed ID: 30838820 [TBL] [Abstract][Full Text] [Related]
10. THE COMBINED USE OF CALCITONIN DOUBLING TIME AND Yang JH; Camacho CP; Lindsey SC; Valente FOF; Andreoni DM; Yamaga LY; Wagner J; Biscolla RPM; Maciel RMB Endocr Pract; 2017 Aug; 23(8):942-948. PubMed ID: 28614009 [TBL] [Abstract][Full Text] [Related]
11. Long-Term Follow-up in Medullary Thyroid Carcinoma. Raue F; Frank-Raue K Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391 [TBL] [Abstract][Full Text] [Related]
14. Estimating the Growth Rate of Lung Metastases in Differentiated Thyroid Carcinoma: Response Evaluation Criteria in Solid Tumors or Doubling Time? Song E; Ahn J; Jeon MJ; Lee SM; Lee JH; Kim TY; Baek JH; Kim WB; Shong YK; Kim WG Thyroid; 2020 Mar; 30(3):418-424. PubMed ID: 31880976 [No Abstract] [Full Text] [Related]
15. An Overview of Medullary Thyroid Cancer Cases Treated at Kuwait Cancer Control Center. Shete J; AlSaleh K; Safwat R; Bedair A; ElSherify M; Hussein A; Nazeeh M; Mohanty A Gulf J Oncolog; 2020 Sep; 1(34):39-47. PubMed ID: 33431361 [TBL] [Abstract][Full Text] [Related]
16. Surufatinib in Chinese Patients with Locally Advanced or Metastatic Differentiated Thyroid Cancer and Medullary Thyroid Cancer: A Multicenter, Open-Label, Phase II Trial. Chen J; Ji Q; Bai C; Zheng X; Zhang Y; Shi F; Li X; Tang P; Xu Z; Huang R; Huang T; Pan Y; Fan S; Zhou J; Su W Thyroid; 2020 Sep; 30(9):1245-1253. PubMed ID: 32075524 [No Abstract] [Full Text] [Related]
17. Disease-free survival and the prognostic factors affecting disease-free survival in patients with medullary thyroid carcinoma: a multicenter cohort study. Zuhur SS; Ozturk BO; Keskin U; Uysal S; Hacioglu A; Avci U; Karsli S; Andac B; Ozbay UN; Kilinc F; Erol S; Catak M; Sodan H; Pekkolay Z; Burhan S; Akbaba G; Ates C; Yorulmaz G; Tekin S; Topcu B; Tuna MM; Kadioglu P; Gonen MS; Karaca Z; Ciftci S; Celik M; Guldiken S; Tuzun D; Altuntas Y; Akturk M; Niyazoglu M; Cinar N; Gul OO; Kebapci MN; Akalin A; Bayraktaroglu T; Elbuken G Endocrine; 2024 Sep; 85(3):1300-1309. PubMed ID: 38570387 [TBL] [Abstract][Full Text] [Related]
18. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study. Rozenblat T; Hirsch D; Robenshtok E; Grozinsky-Glasberg S; Gross DJ; Mazeh H; Benbassat C; Twito O; Levy S; Mizrachi A; Shpitzer T; Bachar G Eur J Surg Oncol; 2020 Nov; 46(11):2023-2028. PubMed ID: 32389525 [TBL] [Abstract][Full Text] [Related]
19. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines. Mitchell AL; Gandhi A; Scott-Coombes D; Perros P J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128 [TBL] [Abstract][Full Text] [Related]
20. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma. Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]